Capnographs

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Loading Image
Loading Image
I now have everything needed for a thorough, well-illustrated answer. Let me compile it.

Capnographs

Terminology

There is frequent confusion between related terms, so clarity here is important:
  • Capnometry - the measurement and quantification of inhaled/exhaled CO2 concentrations at the airway opening
  • Capnography - not only the method of CO2 measurement, but also its graphic display as a function of time or volume
  • Capnometer - a device that measures CO2 (may display a numeric value only)
  • Capnograph - a device that records and displays CO2 concentrations, usually as a function of time
  • Capnogram - the graphic waveform the capnograph generates
Miller's Anesthesia, 10e, p. 5482-5483

How Capnographs Work

The most common clinical method is nondispersive infrared (NDIR) absorption. CO2 absorbs infrared light over a narrow bandwidth centered around 4.26 μm. The capnograph passes an infrared beam through a gas sample; a photodetector measures the transmitted light - less transmission = more CO2.
Most devices use a rotating chopper disk (~60 rpm) that alternately directs the beam through:
  1. A sample cell containing the gas to be analyzed
  2. A reference cell free of CO2
  3. A fully blocked position (background)
This three-signal approach allows continuous, real-time CO2 concentration estimation. Solid-state devices may use a beam splitter instead of a chopper wheel.
Note: The absorption spectra of CO2 partially overlaps with water vapour and nitrous oxide, so infrared filters and compensation algorithms are used to minimize interference.
Miller's Anesthesia, 10e, p. 5484

Types: Sidestream vs. Mainstream

FeatureSidestream (Diverting)Mainstream (Non-diverting)
Sensor locationAt the monitor console (remote)In-line at the airway
MechanismPump aspirates gas via tubingSensor sits directly in the circuit
Gas withdrawal rate30-500 mL/minNone (no gas removed)
Common useMost OR settingsNICU, infants
Key advantagesNo added airway weight, can analyze multiple gasesNo lag time, no aspiration artifacts
Key disadvantagesLag time (~1 s), water condensation in tubing, gas lost from circuitHeavier at airway, sensor can become contaminated, heated to prevent condensation
For sidestream units, high aspiration rates (up to 250 mL/min) improve sensitivity and reduce lag time, but in small patients (pediatric), high aspiration can entrain fresh gas and dilute the ETCO2 reading. Low rates (<50 mL/min) can underestimate ETCO2 during rapid ventilation.
Morgan & Mikhail's Clinical Anesthesiology, 7e, p. 227; Miller's Anesthesia, 10e, p. 5485

The Normal Capnogram (Time-Based)

Representative time capnogram showing phases 0-IV across three breaths
The capnogram is divided into phases:
PhaseSegmentWhat it represents
0 (Inspiration)Descending to zeroInspiratory limb; CO2 returns to zero (or baseline)
IFlat at zeroAnatomical dead space gas - no CO2
IIRapid upstrokeMixed dead space + alveolar gas emerging
IIIAlveolar plateauPure alveolar gas; the peak value = PETCO2
IVLate upstroke (dashed)Seen in some patients; reflects cardiogenic oscillations or terminal alveolar emptying
The α angle (between phases II and III) and β angle (between phase III and the descending limb) are also informative - a widened α angle suggests obstructive pathology.
Normal PETCO2 = 35-45 mmHg (approximates PaCO2 with a 2-5 mmHg gradient; alveolar dead space accounts for PETCO2 being slightly lower than PaCO2).
Miller's Anesthesia, 10e, p. 5483

Abnormal Capnogram Patterns

Abnormal capnogram waveform patterns A through E
PatternWhat you seeCause
A - NormalClear plateau reaching ~40 mmHgNormal
B - COPD/ObstructiveNo true alveolar plateau; continuously rising phase III; no distinct plateau before next inspirationObstructive lung disease (COPD, asthma) - uneven emptying of lung units
C - Spontaneous effortA notch or dip during phase IIIPatient breathing against the ventilator; spontaneous respiratory effort during phase III
D - CO2 rebreathingInspired baseline does not return to zeroExhausted CO2 absorbent, incompetent expiratory valve, or inadequate fresh gas flow
E - Incompetent inspiratory valveExhaled gas persists into part of the inspiratory cycle; slow descentIncompetent inspiratory valve in the breathing circuit
Morgan & Mikhail's Clinical Anesthesiology, 7e, p. 227-228

Key Clinical Uses

1. Confirming ETT/LMA Placement

Capnography is the gold standard for confirming endotracheal tube placement. It rapidly and reliably detects esophageal intubation - the most critical use. Although there may be some CO2 in the stomach from swallowed expired air, this washes out within a few breaths. Capnography does not reliably detect mainstem bronchial intubation.

2. Ventilation Monitoring

  • Standard of care during general anesthesia
  • Mandated during moderate and deep procedural sedation
  • Detects hypoventilation earlier than pulse oximetry, even with supplemental oxygen in use

3. Circuit Integrity

  • Sudden drop to zero during expiration - circuit disconnection
  • CO2 in the inspiratory limb - exhausted absorbent or valve failure

4. Cardiovascular Events

The PaCO2-ETCO2 gradient (normally 2-5 mmHg) reflects alveolar dead space. Any reduction in lung perfusion widens this gradient and decreases ETCO2:
  • Pulmonary embolism
  • Air embolism
  • Decreased cardiac output / hypotension
  • Cardiac arrest (ETCO2 <10 mmHg is a poor prognostic sign; rise during CPR suggests ROSC)

5. Metabolic States

  • Malignant hyperthermia - causes a marked, rapid rise in ETCO2 (increased metabolic CO2 production)
  • Hyperthyroidism, sepsis - elevated ETCO2
  • Hypothermia, hypothyroidism - reduced ETCO2
Morgan & Mikhail's Clinical Anesthesiology, 7e, p. 227-228; Barash Clinical Anesthesia, 9e, p. 2111-2112

Limitations

  • Not equivalent to ABG for PaCO2 assessment in disease states with increased dead space (e.g. emphysema, PE, low cardiac output) - the gradient widens unpredictably
  • Cannot detect nitrogen directly (relevant for air embolism and preoxygenation monitoring) - infrared analyzers must infer N2
  • Cannot detect xenon anesthesia; not useful with total IV anesthesia (no volatile agent)
  • Water condensation in sidestream tubing can obstruct the sampling line and give erroneous readings
  • In pediatric patients, high aspiration rates may dilute the sample and underestimate ETCO2
Barash Clinical Anesthesia, 9e, p. 2111-2112

Summary

A capnograph is an infrared-based CO2 monitor that displays a real-time waveform (the capnogram) of exhaled CO2 across the respiratory cycle. It is one of the most information-rich monitors in anesthesia and emergency medicine - providing simultaneous insight into ventilation adequacy, airway placement, circuit integrity, cardiac output, and metabolic state. The normal waveform has a flat phase I, rising phase II, and alveolar plateau (phase III) reaching PETCO2 ~35-45 mmHg; deviations from this pattern point to specific clinical problems.

ED 95 for 10 mark Question for MD anaesthesia exam

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
I have enough high-quality content for a full 10-mark exam answer. Let me compose it now.

ED95 of Neuromuscular Blocking Drugs

Model Answer - MD Anaesthesia (10 Marks)


1. Definition (2 marks)

ED95 stands for the Effective Dose that produces 95% depression of maximal muscle twitch response in 50% of patients studied under defined anesthetic conditions.
It is important to understand the precise terminology here, as it differs from the conventional pharmacological use of "ED95":
  • In conventional pharmacology, ED95 means the dose effective in 95% of the population.
  • In neuromuscular pharmacology, ED95 = the median dose (effective in 50% of patients) required to produce 95% depression of the single twitch response (measured at the adductor pollicis muscle using ulnar nerve stimulation).
This is derived from a dose-response (quantal) curve - a sigmoid curve plotting cumulative percentage of patients against dose. The ED95 is read off at the 95% twitch-suppression point on this curve.
Barash Clinical Anesthesia, 9e, p. 1604

2. How ED95 Expresses Potency (1 mark)

ED95 is the standard measure of potency of neuromuscular blocking drugs (NMBDs). A lower ED95 = more potent drug (smaller dose needed for effect). A higher ED95 = less potent drug.
Potency and onset are inversely related (see below).

3. ED95 Values of Clinically Used NMBDs (2 marks)

DrugClassDurationED95 (mg/kg)Intubating Dose (2× ED95)
SuccinylcholineDepolarizingUltra-short0.3 mg/kg*1.0-1.5 mg/kg
RocuroniumAminosteroidIntermediate0.3 mg/kg0.6 mg/kg
VecuroniumAminosteroidIntermediate0.05 mg/kg0.1 mg/kg
CisatracuriumBenzylisoquinoliniumIntermediate0.05 mg/kg0.1-0.15 mg/kg
AtracuriumBenzylisoquinoliniumIntermediate0.23 mg/kg0.5 mg/kg
PancuroniumAminosteroidLong0.07 mg/kg0.1 mg/kg
MivacuriumBenzylisoquinoliniumShort0.08 mg/kg0.15-0.2 mg/kg
*Succinylcholine ED95 by cumulative dose-response methods is actually <0.3 mg/kg; the conventional dose of 1 mg/kg = ~3× ED95.
Key fact: The four most commonly used NMBDs in current practice have an ED95 of either 0.3 mg/kg (succinylcholine, rocuronium) or 0.05 mg/kg (cisatracurium, vecuronium).
Barash Clinical Anesthesia, 9e, p. 1597; Miller's Anesthesia, 10e, p. 3229

4. Clinical Significance of ED95: Intubating Dose (1 mark)

The standard intubating dose = 2× ED95. This provides:
  • Complete neuromuscular blockade in the vast majority of patients
  • Acceptable onset time
  • Reliable intubating conditions
If the trachea has already been intubated (e.g., with succinylcholine) and an NMBD is needed only for surgical relaxation, a dose slightly less than the ED95 is often sufficient for most surgical settings.
Clinical PurposeDose Used
Surgical relaxation only~0.5-1 × ED95
Standard tracheal intubation2 × ED95
Rapid sequence intubation (rocuronium)3-4 × ED95 (0.9-1.2 mg/kg)
Miller's Anesthesia, 10e, p. 3269

5. Inverse Potency-Onset Relationship (2 marks)

This is a high-yield concept for exam purposes.
The less potent the NMBD, the faster its onset of action (at equipotent doses).
Mechanism:
  • At equipotent (2× ED95) doses, a less potent drug requires more molecules to achieve the same effect
  • More molecules = higher molar concentration delivered to the neuromuscular junction
  • Higher concentration gradient across the NMJ = faster diffusion and faster receptor occupancy
  • Therefore, onset is faster
Rocuronium (ED95 = 0.3 mg/kg, molar ED95 = 0.54 μM/kg) has approximately:
  • 13% the molar potency of vecuronium
  • 9% the molar potency of cisatracurium
This explains why rocuronium at 1.2 mg/kg (4× ED95) achieves intubating conditions within 60 seconds, comparable to succinylcholine - by giving a very large number of molecules.
Mathematically: Onset time ∝ 1/Molar potency (i.e., onset time decreases as ED50 or ED95 increases)
This relationship holds for most steroidal NMBDs (exception: atracurium does not follow this rule).
Miller's Anesthesia, 10e, p. 3272; Barash Clinical Anesthesia, 9e, p. 1615

6. Factors Affecting the ED95 Value (1 mark)

The ED95 is not a fixed number - it changes under different conditions:
FactorEffect on ED95
Volatile anesthetic agents (sevoflurane, isoflurane, desflurane)Decrease ED95 by 20-50% (potentiate NMBDs) - so a lower dose achieves the same effect
Nitrous oxideMinor potentiation
HypothermiaPotentiates NMBDs (decreased metabolism, prolonged duration)
Acid-base statusRespiratory acidosis potentiates; alkalosis antagonizes
HypermagnesaemiaPotentiates block
Aminoglycoside antibioticsPotentiate block
Myasthenia gravisExtreme sensitivity - ED95 much lower for NDNMBDs
Burns, denervation (>24h)Resistance to NMBDs (increased ACh receptors)
Clinically: during volatile anesthesia, the intubating dose may be reduced by ~40% relative to doses used under N2O/O2/opioid anesthesia.
Miller's Anesthesia, 10e, p. 3265; Barash Clinical Anesthesia, 9e, p. 1615

7. Interpatient Variability (1 mark)

ED95 represents the median population response, but individual variation is enormous and clinically important:
  • In a classic study (Katz, 1967), 0.1 mg/kg curare caused zero twitch depression in 6% of patients yet complete abolition in 7% - the same dose!
  • Duration of action at equipotent doses is equally unpredictable
  • Age, sex, body build, and ASA status cannot predict individual response to a given dose
  • This variability is why quantitative neuromuscular monitoring (TOF ratio) is essential and cannot be replaced by clinical assessment or time
Barash Clinical Anesthesia, 9e, p. 1606

Summary Table

ConceptKey Point
DefinitionMedian dose causing 95% twitch depression in 50% of patients
Standard intubating dose2× ED95
RSI dose (rocuronium)4× ED95 (1.2 mg/kg)
Low ED95High potency
High ED95Low potency, but faster onset
Volatile agentsReduce ED95 by ~40%
MonitoringEssential due to wide interpatient variation

Sources: Barash, Cullen & Stoelting's Clinical Anesthesia 9e (pp. 1597-1615); Miller's Anesthesia 10e (pp. 3229-3275)

Convert in PDF

Reading File
Running Command
Running Command
Writing File
Running Command
Your PDF is ready. It includes all 7 sections with mark allocations, formatted tables, and source references:

ED95 NMBDs MD Anaesthesia

PDF Document · PDF

The document contains:
  • Title page header with exam context (10 marks)
  • All 7 sections with mark breakdowns
  • Colour-coded tables for ED95 values, intubating doses, factors affecting ED95, and the summary
  • Source references at the bottom (Barash 9e + Miller's 10e)

Can you explain inter patient variability better

Finding Sources
Finding Sources
Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
This is a shared conversation. Sign in to Orris to start your own chat.